本页面由Tiger Trade Technology Pte. Ltd.提供服务

Altimmune, Inc.

3.02
-0.1800-5.63%
盘后3.070.0500+1.66%19:59 EDT
成交量:267.49万
成交额:819.05万
市值:3.93亿
市盈率:-3.02
高:3.19
开:3.16
低:3.02
收:3.20
52周最高:7.73
52周最低:2.90
股本:1.30亿
流通股本:1.24亿
量比:0.52
换手率:2.16%
股息:- -
股息率:- -
每股收益(TTM):-0.9999
每股收益(LYR):-0.9999
净资产收益率:-50.57%
总资产收益率:-28.17%
市净率:1.75
市盈率(LYR):-3.02

数据加载中...

2023/02/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/20

重要事件披露

8-K - Current report
2022/11/10

重要事件披露

8-K - Current report
2022/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/29

重要事件披露

8-K - Current report
2022/09/14

重要事件披露

8-K - Current report
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/12

重要事件披露

8-K - Current report
2022/03/24

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]